{
  "cik": 1434316,
  "cik_padded": "0001434316",
  "entityName": "FATE THERAPEUTICS INC",
  "fiscal_years": [
    {
      "accn": "0001193125-26-073699",
      "filed": "2026-02-26",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD"
      },
      "fundamentals": {
        "capex": 5953000.0,
        "cash": 46628000.0,
        "eps_diluted": -1.15,
        "free_cash_flow": -112037000.0,
        "net_income": -136315000.0,
        "operating_cash_flow": -106084000.0,
        "operating_income": -147704000.0,
        "revenue": 6646000.0,
        "stockholders_equity": 207184000.0,
        "total_assets": 318937000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "revenue_growth_yoy": -0.5124348910571491,
        "roa_avg2y": -0.35889793860440133,
        "roa_period_end": -0.4274041581879807,
        "roe_avg2y": -0.5183966838432431,
        "roe_period_end": -0.6579417329523516
      }
    },
    {
      "accn": "0001193125-26-073699",
      "filed": "2026-02-26",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD"
      },
      "fundamentals": {
        "capex": 730000.0,
        "cash": 36056000.0,
        "eps_diluted": -1.64,
        "free_cash_flow": -123604000.0,
        "net_income": -186262000.0,
        "operating_cash_flow": -122874000.0,
        "operating_income": -210276000.0,
        "revenue": 13631000.0,
        "stockholders_equity": 318726000.0,
        "total_assets": 440694000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "revenue_growth_yoy": -0.7854500810602364,
        "roa_avg2y": -0.3934097291086491,
        "roa_period_end": -0.42265608335942856,
        "roe_avg2y": -0.5421346066248219,
        "roe_period_end": -0.5843953740830682
      }
    },
    {
      "accn": "0001193125-26-073699",
      "filed": "2026-02-26",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD"
      },
      "fundamentals": {
        "capex": 6153000.0,
        "cash": 41870000.0,
        "eps_diluted": -1.64,
        "free_cash_flow": -138416000.0,
        "net_income": -160928000.0,
        "operating_cash_flow": -132263000.0,
        "operating_income": -190511000.0,
        "revenue": 63533000.0,
        "stockholders_equity": 368417000.0,
        "total_assets": 506217000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "revenue_growth_yoy": -0.34025960539979233,
        "roa_avg2y": -0.2656064064539874,
        "roa_period_end": -0.3179031917142253,
        "roe_avg2y": -0.3776074785652943,
        "roe_period_end": -0.4368093763317111
      }
    },
    {
      "accn": "0000950170-25-033510",
      "filed": "2025-03-05",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD"
      },
      "fundamentals": {
        "capex": 35566000.0,
        "cash": 61333000.0,
        "eps_diluted": -2.91,
        "free_cash_flow": -283774000.0,
        "net_income": -281721000.0,
        "operating_cash_flow": -248208000.0,
        "operating_income": -308386000.0,
        "revenue": 96300000.0,
        "stockholders_equity": 483939000.0,
        "total_assets": 705561000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "revenue_growth_yoy": 0.7243849156609247,
        "roa_avg2y": -0.34630390850489484,
        "roa_period_end": -0.39928652519059304,
        "roe_avg2y": -0.484565828185456,
        "roe_period_end": -0.5821415508979437
      }
    },
    {
      "accn": "0000950170-24-020158",
      "filed": "2024-02-26",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD"
      },
      "fundamentals": {
        "capex": 50704000.0,
        "cash": 133583000.0,
        "eps_diluted": -2.24,
        "free_cash_flow": -213574000.0,
        "net_income": -212151000.0,
        "operating_cash_flow": -162870000.0,
        "operating_income": -216994000.0,
        "revenue": 55846000.0,
        "stockholders_equity": 678838000.0,
        "total_assets": 921455000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "revenue_growth_yoy": 0.7766113125914614,
        "roa_avg2y": -0.27482265828622354,
        "roa_period_end": -0.2302347917152764,
        "roe_avg2y": -0.39904898319638327,
        "roe_period_end": -0.31252080761536627
      }
    },
    {
      "accn": "0000950170-23-005067",
      "filed": "2023-02-28",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD"
      },
      "fundamentals": {
        "capex": 4932000.0,
        "cash": 167347000.0,
        "eps_diluted": -2.1,
        "free_cash_flow": -44161000.0,
        "net_income": -173387000.0,
        "operating_cash_flow": -39229000.0,
        "operating_income": -128085000.0,
        "revenue": 31434000.0,
        "stockholders_equity": 384445000.0,
        "total_assets": 622457000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "revenue_growth_yoy": 1.943258426966292,
        "roa_avg2y": -0.3749998648255547,
        "roa_period_end": -0.2785525747160045,
        "roe_avg2y": -0.5511338983885913,
        "roe_period_end": -0.4510059956560756
      }
    },
    {
      "accn": "0000950170-23-005067",
      "filed": "2023-02-28",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD"
      },
      "fundamentals": {
        "capex": 7395000.0,
        "cash": 99814000.0,
        "free_cash_flow": -90570000.0,
        "net_income": -98149000.0,
        "operating_cash_flow": -83175000.0,
        "operating_income": -100727000.0,
        "revenue": 10680000.0,
        "stockholders_equity": 244756000.0,
        "total_assets": 302274000.0
      },
      "period_end": "2019-12-31",
      "ratio_units": {
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "revenue_growth_yoy": 1.2531645569620253,
        "roa_avg2y": -0.3809348231924332,
        "roa_period_end": -0.32470209147991563,
        "roe_avg2y": -0.4844172990314023,
        "roe_period_end": -0.401007534033895
      }
    },
    {
      "accn": "0001564590-21-008086",
      "filed": "2022-02-28",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD"
      },
      "fundamentals": {
        "capex": 2303000.0,
        "cash": 190514000.0,
        "free_cash_flow": -40953000.0,
        "net_income": -66598000.0,
        "operating_cash_flow": -38650000.0,
        "operating_income": -67092000.0,
        "revenue": 4740000.0,
        "stockholders_equity": 160469000.0,
        "total_assets": 213032000.0
      },
      "period_end": "2018-12-31",
      "ratio_units": {
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "revenue_growth_yoy": 0.1544081831466147,
        "roa_avg2y": -0.41842902200273935,
        "roa_period_end": -0.3126197003267115,
        "roe_avg2y": -0.5604524148145654,
        "roe_period_end": -0.41502096978232556
      }
    },
    {
      "accn": "0001564590-21-008086",
      "filed": "2021-02-24",
      "fiscal_year": 2017,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD"
      },
      "fundamentals": {
        "capex": 1725000.0,
        "cash": 88952000.0,
        "free_cash_flow": -38542000.0,
        "net_income": -42952000.0,
        "operating_cash_flow": -36817000.0,
        "operating_income": -42125000.0,
        "revenue": 4106000.0,
        "stockholders_equity": 77189000.0,
        "total_assets": 105292000.0
      },
      "period_end": "2017-12-31",
      "ratio_units": {
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "revenue_growth_yoy": -0.06724216265333939,
        "roa_avg2y": -0.4287910552061495,
        "roa_period_end": -0.40793222656991984,
        "roe_avg2y": -0.5713867622702753,
        "roe_period_end": -0.5564523442459418
      }
    },
    {
      "accn": "0001564590-20-008141",
      "filed": "2020-03-02",
      "fiscal_year": 2016,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD"
      },
      "fundamentals": {
        "capex": 457000.0,
        "cash": 88609000.0,
        "free_cash_flow": -30280000.0,
        "net_income": -33462000.0,
        "operating_cash_flow": -29823000.0,
        "operating_income": -31963000.0,
        "revenue": 4402000.0,
        "stockholders_equity": 73154000.0,
        "total_assets": 95048000.0
      },
      "period_end": "2016-12-31",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "roa_period_end": -0.3520536991835704,
        "roe_period_end": -0.45741859638570687
      }
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-073699",
    "filed": "2026-02-26",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2836",
  "sic_description": "Biological Products, (No Diagnostic Substances)",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001434316.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001434316.json"
  },
  "ticker": "FATE"
}
